Jove
Visualize
Contact Us

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

32.6K
Overview
32.6K
T Cell Types and Functions01:24

T Cell Types and Functions

2.8K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.8K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

4.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.6K
Allergic Drug Reactions01:27

Allergic Drug Reactions

1.5K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.5K
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

72
Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
72

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Uncovering the Complexities of IL-33 Signaling in Chronic Obstructive Pulmonary Disease.

American journal of respiratory and critical care medicine·2023
Same author

Risankizumab in Severe Asthma - A Phase 2a, Placebo-Controlled Trial.

The New England journal of medicine·2021
Same author

IL-6 effector function of group 2 innate lymphoid cells (ILC2) is NOD2 dependent.

Science immunology·2021
Same author

Human retinoic acid-regulated CD161<sup>+</sup> regulatory T cells support wound repair in intestinal mucosa.

Nature immunology·2018
Same author

CD1a presentation of endogenous antigens by group 2 innate lymphoid cells.

Science immunology·2017
Same author

Group 2 Innate Lymphoid Cells Express Functional NKp30 Receptor Inducing Type 2 Cytokine Production.

Journal of immunology (Baltimore, Md. : 1950)·2015
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Feb 25, 2026

Author Spotlight: Achieving High-Purity In Vitro Differentiation of Th17 Cells Using Cytokine Concentration Modulation
07:46

Author Spotlight: Achieving High-Purity In Vitro Differentiation of Th17 Cells Using Cytokine Concentration Modulation

Published on: October 25, 2024

4.5K

Pinning allergies on pathogenic TH2 cells.

David J Cousins1

  • 1Department of Infection, Immunity and Inflammation, National Institute for Health Research Leicester Biomedical Research Centre, Leicester Institute for Lung Health, University of Leicester, Leicester LE3 9QP, UK.

Science Translational Medicine
|August 4, 2017
PubMed
Summary

A novel proinflammatory T helper 2 (TH2) cell subtype expressing CD161 drives allergic disease. Allergen-specific immunotherapy eliminates these pathogenic TH2 cells.

More Related Videos

Isolation and Th17 Differentiation of Na&#239;ve CD4 T Lymphocytes
12:59

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes

Published on: September 26, 2013

35.6K
Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
10:39

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

8.2K

Related Experiment Videos

Last Updated: Feb 25, 2026

Author Spotlight: Achieving High-Purity In Vitro Differentiation of Th17 Cells Using Cytokine Concentration Modulation
07:46

Author Spotlight: Achieving High-Purity In Vitro Differentiation of Th17 Cells Using Cytokine Concentration Modulation

Published on: October 25, 2024

4.5K
Isolation and Th17 Differentiation of Na&#239;ve CD4 T Lymphocytes
12:59

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes

Published on: September 26, 2013

35.6K
Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
10:39

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

8.2K

Area of Science:

  • Immunology
  • Allergy Research
  • Cell Biology

Background:

  • Allergic diseases involve complex immune responses.
  • T helper 2 (TH2) cells are key players in allergic inflammation.
  • The specific pathogenic TH2 cell subtype driving disease remained unidentified.

Purpose of the Study:

  • To identify the pathogenic TH2 cell subtype responsible for allergic disease.
  • To investigate the role of CD161 expression in TH2 cell function.
  • To determine if allergen-specific immunotherapy targets this pathogenic cell type.

Main Methods:

  • Flow cytometry to identify T cell subsets.
  • Analysis of T cell surface markers, including CD161.
  • Assessment of T cell cytokine production.
  • Evaluation of T cell populations before and after immunotherapy.

Main Results:

  • A distinct proinflammatory TH2 cell subtype expressing CD161 was identified.
  • This CD161+ TH2 cell population was significantly expanded in patients with allergic disease.
  • Allergen-specific immunotherapy led to the deletion of these pathogenic CD161+ TH2 cells.

Conclusions:

  • CD161+ TH2 cells represent a critical pathogenic cell type in allergic diseases.
  • Targeting and eliminating CD161+ TH2 cells is a potential therapeutic strategy for allergies.
  • Allergen-specific immunotherapy effectively removes these disease-driving cells.